InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.31
(
0.22%
)
Bitcoin
64,165.39
(
0.26%
)
Post# of 1794
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

EZ Trader

Send PM Follow Ignore
Followers 2
Posts 50
Boards Moderated 0
Alias Born 04/04/2014

EZ Trader

Re: None

Thursday, 06/12/2014 12:50:08 PM

Thursday, June 12, 2014 12:50:08 PM

Post# of 1794
Conversely, it’s not uncommon for disappointing clinical data to cause a company’s valuation to crumble in the blink of an eye. Take a look at what happened on Wednesday to Orexigen Therapeutics (OREX) or in the past few months as Prana Biotechnology (PRAN) shares were scalped by about 75 percent in two days late in March or the valuation of Athersys (ATHX) getting halved late in April on disappointing trial data.

http://www.equities.com/editors-desk/stocks/healthcare/understanding-impact-clinical-trials-on-shareholder-value
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!